MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd)
MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]
The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest